4.6 Article

A novel role of breast cancer-derived hyaluronan on inducement of M2-like tumor-associated macrophages formation

Journal

ONCOIMMUNOLOGY
Volume 5, Issue 6, Pages -

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/2162402X.2016.1172154

Keywords

Breast cancer; CD44; ERK1/2; hyaluronan; STAT3; tumor-associated macrophages

Funding

  1. National Natural Science Foundation of China [81272479, 81402419, 81572821, 81502490, 81502491]
  2. Natural Science Foundation of Shanghai Municipality [14YF1412200]
  3. Program of Shanghai Leading Talents [2013-038]
  4. Shanghai Shen-Kang Hospital Development Center [SHDC22014004]
  5. Shanghai Jiao Tong University Affiliated Sixth People's Hospital [1655]

Ask authors/readers for more resources

Microenvironmental signals determine the differentiation types and distinct functions of macrophages. Tumor-associated macrophages (TAM) constitute major infiltrates around solid tumor cells and accelerate tumor progression due to their immunosuppressive functions. However, the mechanisms through which tumor microenvironment modulates macrophages transition are not completely elucidated. Hyaluronan (HA), a prominent component in tumor microenvironment, is a notable immunoregulator and its high level is often related to poor prognosis. Herein, we found that the number of M2 macrophages was highly correlated with HA expression in tumor tissues from breast cancer patients. Experimental data showed that breast cancer-derived HA stimulated M2-like TAM formation in a mouse model and had multiple effects on macrophages transformation in vitro, including upregulating CD204, CD206, IL-10 and TGF-beta, activating STAT3 signal, and suppressing killing capacity. These data indicate that HA derived from breast cancer activates macrophages in an alternative manner. Further mechanism study revealed that HA-CD44-ERK1/2-STAT3 pathway served as an important regulator in M2-like TAM formation. Therefore, targeting TAM by abrogating HA-CD44 interaction may be a potential strategy for breast cancer immunotherapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available